Metabolic disorder

CRISPR Medicine in 2021 – What a Phenomenal Year...

Dec. 28, 2021

In 2021, we've seen positive clinical data for the first ever in vivo CRISPR medicines, base editors are heading for the clinic, and CRISPR therapies...

First CRISPR Therapy for Type 1 Diabetes Set to...

Nov. 17, 2021

CRISPR Therapeutics and ViaCyte announced yesterday that Canada’s medical agency Health Canada has approved their clinical trial application for...

Metabolic disorder

Relapsed/Refractory Hematologic Malignancies (NCT06492304)
Sponsors:
CRISPR Therapeutics

IND Enabling

Phase I

Phase II

Phase III